Abstract
To assess the effects of medetomidine, an α 2 -adrenoceptor agonist, on cardiac function, radionuclide ventriculograms (RNV) were performed in 7 normal anesthetised cats before and after im administration of the drug. Ejection fraction (EF), peak ventricular ejection rate (PVER), peak ventricular filling rate (PVFR), time to peak ejection (TPE) and time to peak filling (TPF) were determined. Medetomidine caused significant reductions in EF (baseline 55.0 ± 10.8%, post medetomidine 43.3 ± 10.7%), PVER (baseline 4.38 ± 0.83 EDV/s, post medetomidine 3.28 ± 0.73 EDV/s) and PVFR (baseline 4.46 ± 1.42 EDV/s, post medetomidine 3.05 ± 1.27 EDV/s). There was also a significant decrease in heart rate following medetomidine administration (baseline 115 ± 27.2 bpm, post medetomidine 100 ± 21.2 bpm). The TPE and TPF did not change significantly following medetomidine. The observed decrease in cardiac function may have been caused by a drug-induced increase in systemic vascular resistance, and the bradycardia due to central nervous system depression.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
